Medical economics

Pfizer and Moderna won't be the only ones to reap huge payday

Pfizer and Moderna appear to be the clear leaders in the race for a COVID-19 vaccine. Pfizer has already begun distribution, and Moderna's entry is on the brink of FDA approval, which would put the two at least weeks ahead ...

Medications

Novo Nordisk woos Belgian nano-drug maker

Denmark's Novo Nordisk, the world's leading insulin manufacturer, announced Monday an offer to buy the Belgian biotech firm Ablynx for 2.6 billion euros ($3.1 billion).

Health

Survey: US health insurance gains pick up (Update)

A growing share of Americans got health insurance as sign-up season for President Barack Obama's health care law neared its end last month, a major survey released Monday has found.

Other

Merck Q4 net drops 14 pct. on generic competition

Merck & Co. reported a 14 percent decline in fourth-quarter profit as generic competition continued to cut into sales of one-time blockbuster medicines, and unfavorable currency exchange rates reduced overseas revenue.

Other

Mallinckrodt buying Cadence Pharma for $1.21B

Health care products company Mallinckrodt is buying Cadence Pharmaceuticals Inc. for about $1.21 billion to help enhance its specialty pharmaceuticals segment.

Health

Fonterra slammed over botulism scare response

New Zealand dairy giant Fonterra bungled its response to a food contamination scare because it was more concerned with market share than public safety, an official inquiry found Tuesday.

page 18 from 20